Mexidol® is an original (reference) drug with a powerful anti-ischemic effect, a unique development in the Russian pharmaceutical industry. Due to its multimodal mechanism of action and broad spectrum of pharmacological effects, Mexidol® is effective in the treatment of acute and chronic diseases caused by ischemia and hypoxia of various origins. Today, the drug is widely used in neurology, internal medicine, neuropediatrics, cardiology, ophthalmology, psychiatry, and addiction medicine.
Video recordings featuring opinions from leading Russian healthcare professionals
detail effective comprehensive treatment options for patients after stroke, chronic cerebral ischemia, and degenerative spinal diseases. They also highlight the specifics of managing elderly and comorbid patients, and demonstrate the potential of using the multimodal drug Mexidol® in these patients.
watch
the video
Why Mexidol®: history of creation, mechanism of action, safety and effect
Ivan Aleksandrovich Shchukin – PhD, Associate Professor of the Department of Neurology, Neurosurgery and Medical Genetics of the Leningrad Branch of the N.I. Pirogov Russian National Research Medical University
watch
the video
Mexidol® for arterial hypertension (AG). AH and cognitive disorders, effective correction methods
Ostroumova Olga Dmitrievna – Doctor of Medical Sciences, Professor, Head. Department of Therapy and Polymorbid Pathology named after. Academician M.S. Vovsi FSBEI DPO RMANPE Ministry of Health of Russia
watch
the video
The effectiveness of Mexidol® for cognitive disorders: decrease in memory, attention, performance
Vladimir Vladimirovich Zakharov – Doctor of Medical Sciences, Professor of the Department of Nervous System Diseases of the Faculty of Medicine of the First Moscow State Medical University named after I.M. Sechenov
watch
the video
Mexidol® with glaucoma and age -related macular degeneration
Egorov Evgeniy Alekseevich – Doctor of Medical Sciences, Professor, President of the Russian Glaucoma Society, Head. Department of Ophthalmology named after. Academician A.P. Nesterov RNRMU named after. N.I. Pie...
watch
the video
Mexidol® — standard of antioxidant neurocytoprotection
Rafael Gegamovich Oganov – Doctor of Medical Sciences, Academician of the Russian Academy of Sciences, Professor, Honorary President of the Russian Society of Cardiology
Voronina Tatyana Aleksandrovna – MD...

The active ingredient in Mexidol® consists
of two related and functionally significant compounds: ethylmethylhydroxypyridine and succinate. Learn more about the mechanism of action and effects of Mexidol®.
A modern approach to treatment is based on scientific findings and facts,
and drug selection directly depends on the quality of preclinical and clinical studies, which form the evidence base
for its use. Mexidol® is an original Russian drug whose efficacy and safety have been proven in accordance
with international standards (GCP).

Information on the indications for use, dosage, duration
of treatment, and methods of administration of Mexidol® can be found here.
The library of research and scientific articles about the drug Mexidol® was collected in one place.
Mexidol® is an original (reference) Russian drug with a powerful anti-ischemic effect, a unique development by leading scientists and clinicians, awarded in 2003 with the prestigious Russian Government Prize
"For the creation and implementation in medical practice of antioxidant drugs for the treatment and prevention of cerebrovascular diseases."

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.
Source of photos and images Shutterstock.com